Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 631 AL 645

Novel Drug Delivery System for Curcumin: Implementation to Improve Therapeutic Efficacy against Neurological Disorders

Mohi-Ud-Din R, Mir RH, Wani TU, Shah AJ, Mohi-Ud-Din I, Dar MA, Pottoo FH.

Comb Chem High Throughput Screen. 2022;25(4):607-615. doi: 10.2174/1386207324666210705114058.

Transcranial magnetic stimulation in animal models of neurodegeneration

Uzair M, Abualait T, Arshad M, Yoo WK, Mir A, Bunyan RF, Bashir S.

Neural Regen Res. 2022 Feb;17(2):251-265. doi: 10.4103/1673-5374.317962.

Association between inflammatory bowel diseases and Parkinson's disease: systematic review and meta-analysis

Zhu Y, Yuan M, Liu Y, Yang F, Chen WZ, Xu ZZ, Xiang ZB, Xu RS.

Neural Regen Res. 2022 Feb;17(2):344-353. doi: 10.4103/1673-5374.317981.

Are Lysosomes Potential Therapeutic Targets for Parkinson's Disease?

Petese A, Cesaroni V, Cerri S, Blandini F.

CNS Neurol Disord Drug Targets. 2022;21(8):642-655. doi: 10.2174/1871527320666210809123630.

The short form of the SUR1 and its functional implications in the damaged brain

Alquisiras-Burgos I, Franco-Pérez J, Rubio-Osornio M, Aguilera P.

Neural Regen Res. 2022 Mar;17(3):488-496. doi: 10.4103/1673-5374.320967.

One ring is sufficient to inhibit α-synuclein aggregation

Pena-DIaz S, Ventura S.

Neural Regen Res. 2022 Mar;17(3):508-511. doi: 10.4103/1673-5374.320973.

Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine

De Iuliis A, Montinaro E, Fatati G, Plebani M, Colosimo C.

Neural Regen Res. 2022 Mar;17(3):523-533. doi: 10.4103/1673-5374.320965.

Circulating extracellular vesicles: friends and foes in neurodegeneration

Picca A, Guerra F, Calvani R, Coelho-Junior HJ, Bucci C, Marzetti E.

Neural Regen Res. 2022 Mar;17(3):534-542. doi: 10.4103/1673-5374.320972.

Outcome Measures for Dementia With Lewy Body Clinical Trials: A Review

Patel B, Irwin DJ, Kaufer D, Boeve BF, Taylor A, Armstrong MJ.

Alzheimer Dis Assoc Disord. 2022 Jan-Mar 01;36(1):64-72. doi: 10.1097/WAD.0000000000000473.

Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer's and Parkinson's Disease

Sood A, Goyal R, Singh H, Behl T, Arora S, Saini B, Kaur R.

CNS Neurol Disord Drug Targets. 2022;21(3):235-245. doi: 10.2174/1871527320666210820092817.

Histamine-4 Receptor: Emerging Target for the Treatment of Neurological Diseases

Shan L, Martens GJM, Swaab DF.

Curr Top Behav Neurosci. 2022;59:131-145. doi: 10.1007/7854_2021_237.

Histamine in the Crosstalk Between Innate Immune Cells and Neurons: Relevance for Brain Homeostasis and Disease

Bernardino L.

Curr Top Behav Neurosci. 2022;59:261-288. doi: 10.1007/7854_2021_235.

Role of Microelectrode Recording in Deep Brain Stimulation of the Pedunculopontine Nucleus: A Physiological Study of Two Cases

Yako T, Kitazawa K, Kobayashi S, Yomo S, Sato H, Johnson LA, Vitek JL, Hashimoto T.

Neuromodulation. 2022 Aug;25(6):925-934. doi: 10.1111/ner.13479. Epub 2022 Jun 14.

Significance of mitochondrial activity in neurogenesis and neurodegenerative diseases

Ozgen S, Krigman J, Zhang R, Sun N.

Neural Regen Res. 2022 Apr;17(4):741-747. doi: 10.4103/1673-5374.322429.

Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects

Rey F, Ottolenghi S, Zuccotti GV, Samaja M, Carelli S.

Neural Regen Res. 2022 Apr;17(4):754-758. doi: 10.4103/1673-5374.322430.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias